Sağlık bülteni
Güvenilir kurumların yayın akışlarından otomatik derlenir; saatte bir güncellenir. Haberin tamamı için kaynağa gidin. Başlıklar kaynak dilinde (İngilizce) gösterilir.
Avrupa Hastalık Önleme ve Kontrol Merkezi (ECDC) · 05.10.2026
Ebola disease outbreak in the Democratic Republic of the CongoSince May 2026, an Ebola virus disease outbreak caused by Bundibugyo virus has been ongoing in the Democratic Republic of the Congo (DRC).
Avrupa Hastalık Önleme ve Kontrol Merkezi (ECDC) · 05.10.2026
Chikungunya virus disease worldwide overviewEvery month ECDC provides detailed epidemiological overview of the worldwide transmission of chikungunya virus disease in its weekly threat report (Communicable Diseases Threat Report).
ABD Gıda ve İlaç Dairesi (FDA) · 05.10.2026
FDA Seeks Public Input to Support Ibogaine ResearchThe U.S. Food and Drug Administration today announced a request for information (RFI) describing approaches the agency is considering for the design of early-phase clinical trials of ibogaine drug products and…
ABD Gıda ve İlaç Dairesi (FDA) · 01.10.2026
FDA Approves First Heart Valve Designed to Grow with ChildrenThe U.S. Food and Drug Administration today approved the Autus Size-Adjustable Valve, a surgically implanted pulmonary heart valve for pediatric patients with congenital pulmonary valve disease.
ABD Gıda ve İlaç Dairesi (FDA) · 30.09.2026
FDA Launches Nationwide Effort to Expand Scientific Expertise and Consumer Voices to Advisory CommitteesThe U.S. Food and Drug Administration today announced a broad, nationwide recruitment effort to expand the range of qualified voices and perspectives on its advisory committees— the independent bodies that inform…
ABD Gıda ve İlaç Dairesi (FDA) · 29.09.2026
FDA Investigation Leads to Charges Against Two Indian Nationals Involved in Transnational Counterfeit Drug Distribution SchemeThe U.S. Attorney’s Office for the Middle District of Florida and the Criminal Division of the U.S. Department of Justice today announced federal charges against Swapnadip Roy, 33, and Vicky Ramancha, 37, both Indian…
Avrupa Hastalık Önleme ve Kontrol Merkezi (ECDC) · 29.09.2026
MERS-CoV worldwide overviewSummary Since the beginning of 2026, and as of 31 August 2026, two MERS cases, including one fatality, have been reported in Saudi Arabia.
ABD Gıda ve İlaç Dairesi (FDA) · 28.09.2026
FDA Approves First Treatment for MCT8 DeficiencyThe U.S. Food and Drug Administration today approved Emcitate (tiratricol) tablets for oral suspension to treat peripheral thyrotoxicosis (excess thyroid hormone levels in the blood that causes symptoms, such as…
ABD Gıda ve İlaç Dairesi (FDA) · 28.09.2026
FDA intends to evaluate changes to the PMTA regulatory frameworkFDA is carefully reviewing its experience implementing the Premarket Tobacco Product Application (PMTA) rule, as well as recent judicial developments, including a federal lawsuit filed in the U.S. District Court for…
Avrupa Hastalık Önleme ve Kontrol Merkezi (ECDC) · 28.09.2026
Cholera worldwide overviewA worldwide epidemiological summary of the countries most affected by cholera.
Avrupa Hastalık Önleme ve Kontrol Merkezi (ECDC) · 28.09.2026
Dengue worldwide overviewEvery month ECDC provides detailed epidemiological overview of the worldwide transmission of dengue in its weekly threat report (Communicable Diseases Threat Report).
ABD Gıda ve İlaç Dairesi (FDA) · 23.09.2026
Federal Court Enters Consent Decree Against Gold Star Distribution, Inc. Following Persistent Insanitary Warehouse ConditionsA U.S. Food and Drug Administration investigation resulted in a federal court order, dated Sept. 21, 2026, stopping a warehouse operator from distributing FDA-regulated products including food, drugs, medical…
ABD Gıda ve İlaç Dairesi (FDA) · 21.09.2026
FDA Updates Regulations to Advance Innovative Alternatives to Animal TestingThe FDA today issued a direct final rule that updates its regulations to clarify that non-animal methods can be used where appropriate for testing the safety of drugs and biological products intended for human use…
ABD Gıda ve İlaç Dairesi (FDA) · 17.09.2026
FDA Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type AThe U.S. Food and Drug Administration today approved Fayuvi (rebisufligene etisparvovec-hopf), the first treatment for pediatric patients with mucopolysaccharidosis type IIIA (MPS IIIA), also known as Sanfilippo…
ABD Gıda ve İlaç Dairesi (FDA) · 15.09.2026
FDA Launches Expedited IND Pilot, Begins Accepting ApplicationsThe U.S. Food and Drug Administration today announced the final design of the Expedited Investigational New Drug (IND) Pilot.
ABD Gıda ve İlaç Dairesi (FDA) · 04.09.2026
FDA Takes Steps to Maintain Newborn Access to Life-Saving Starter Nutrition ProductsThe U.S. Food and Drug Administration today announced it is taking action, consistent with the Trump administration’s commitment to protecting vulnerable patients and maintaining access to critical medical products,…
ABD Gıda ve İlaç Dairesi (FDA) · 04.09.2026
FDA Grants Accelerated Approval to a New Breast Cancer TreatmentThe U.S. Food and Drug Administration today expanded treatment options for adult patients with advanced breast cancer, reflecting the FDA’s commitment to advancing medical innovation and getting new treatments to…
ABD Gıda ve İlaç Dairesi (FDA) · 03.09.2026
FDA Approves First Drug to Treat Alexander DiseaseThe U.S. Food and Drug Administration has approved Zanvastro (zilganersen) injection for the treatment of Alexander disease in pediatric and adult patients.
ABD Gıda ve İlaç Dairesi (FDA) · 03.09.2026
FDA Issues Emergency Use Authorization for Drugs to Prevent and Treat New World Screwworm in Dogs and CatsThe U.S. Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Capstar (nitenpyram) tablets and revised the EUA for Nitenpyram Tablets, the generic version of Capstar
ABD Gıda ve İlaç Dairesi (FDA) · 03.09.2026
FDA Seeks Public Input to Advance Development of Botanical Drug ProductsThe U.S. Food and Drug Administration today announced a request for information (RFI) to gather public input on opportunities to advance the development of botanical drug products.
ABD Gıda ve İlaç Dairesi (FDA) · 28.08.2026
FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood DisorderThe U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cells.
ABD Gıda ve İlaç Dairesi (FDA) · 27.08.2026
FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in AdultsThe U.S. Food and Drug Administration has approved Lisraya (brepocitinib) tablets for the treatment of dermatomyositis in adults.
ABD Gıda ve İlaç Dairesi (FDA) · 27.08.2026
FDA Issues Emergency Use Authorization for Generic Drug to Prevent New World Screwworm in CattleFDA issues Emergency Use Authorization (EUA) for Bimectin (ivermectin) injection for the prevention of New World screwworm (NWS) infestations (myiasis) in cattle when administered within 24 hours of birth, at the…
ABD Gıda ve İlaç Dairesi (FDA) · 26.08.2026
FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic CancerThe U.S. Food and Drug Administration today approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic…
ABD Gıda ve İlaç Dairesi (FDA) · 25.08.2026
FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood SugarThe U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.
Avrupa Hastalık Önleme ve Kontrol Merkezi (ECDC) · 20.08.2026
Epidemiological update – 11 August 2026: Imported case of Andes hantavirus in the EU/EEAOn 6 August 2026, French public health authorities reported an imported case of Andes hantavirus infection in a traveller from Argentina.
Avrupa Hastalık Önleme ve Kontrol Merkezi (ECDC) · 26.05.2026
Andes hantavirus outbreak in cruise shipECDC was notified on 2 May 2026 of a cluster of severe respiratory illness on MV Hondius, a Dutch-flagged cruise ship with passengers and crew from 23 countries, including nine EU/EEA countries. The virus has been…
Avrupa Hastalık Önleme ve Kontrol Merkezi (ECDC) · 20.05.2026
Epidemiological update: Spread of multidrug-resistant and extensively-drug resistant Shigella in EuropeSince 2023, 14 countries have reported more than 2 300 infections caused by multidrug-resistant (MDR) or extensively drug-resistant (XDR) Shigella sonnei and Shigella flexneri to ECDC. Seven genetically distinct…
Avrupa Hastalık Önleme ve Kontrol Merkezi (ECDC) · 13.05.2026
Mpox worldwide overviewEvery month ECDC provides detailed epidemiological overview of the worldwide transmission of mpox in its weekly threat report.
Avrupa Hastalık Önleme ve Kontrol Merkezi (ECDC) · 18.03.2026
Epidemiological update: Shigellosis and other gastrointestinal infections in travellers returning from Cabo VerdeAs of March 2026, over 1 000 confirmed and possible cases of shigellosis and other gastrointestinal infections, including salmonellosis, have been detected in travellers returning from Cabo Verde to several countries…
Dünya Sağlık Örgütü (WHO) · 25.02.2026
WHO Director-General visits Jordan to recognize strong collaboration on health system delivery, emergency relief and advancing mental healthThe Director-General of the World Health Organization, Dr Tedros Adhanom Ghebreyesus, today concluded the first day of his two-day State visit to the Hashemite Kingdom of Jordan, underscoring the strong partnership…
Dünya Sağlık Örgütü (WHO) · 24.01.2026
WHO statement on notification of withdrawal of the United StatesWHO regrets the United States’ notification of withdrawal from WHO – a decision that makes both the United States and the world less safe. The notification of withdrawal raises issues that will be considered by the…
Dünya Sağlık Örgütü (WHO) · 30.07.2025
Paying tribute to David NabarroTribute to Dr David Nabarro
Dünya Sağlık Örgütü (WHO) · 23.07.2025
Timor-Leste certified malaria-free by WHOThe World Health Organization (WHO) has certified Timor-Leste as malaria-free, a remarkable achievement for a country that prioritized the disease and embarked on a concerted, nation-wide response shortly after…
Dünya Sağlık Örgütü (WHO) · 24.05.2025
African Union and World Health Organization renew strategic partnership to drive impact and strengthen health systems in AfricaThe World Health Organization (WHO) and the African Union (AU) Commission renewed their longstanding strategic partnership today with the signing of an updated Memorandum of Understanding (MoU) on the sidelines of…
Dünya Sağlık Örgütü (WHO) · 19.05.2025
WHO’s strategic engagement with philanthropies: advancing global health and resilient health systemsPhilanthropic support plays a vital role in enabling countries to build stronger health systems and advance towards health equity. From vaccine equity and pandemic preparedness to primary health care, the…
Dünya Sağlık Örgütü (WHO) · 10.04.2025
Worldwide rally for maternal and newborn health marks World Health Day 2025On the occasion of the World Health Day 2025 dedicated to the theme of Healthier beginnings, hopeful futures, over 100 global WHO offices have organized wide-ranging public advocacy actions in collaboration with…
Dünya Sağlık Örgütü (WHO) · 01.04.2025
Strengthening public health across Lebanon with EIB GlobalDr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), and Thomas Östros, Vice-President of the European Investment Bank (EIB Global), met at the EIB Group Forum in Luxembourg and…
Dünya Sağlık Örgütü (WHO) · 11.03.2025
Frank, in-depth discussion as Belgium and WHO map ahead priorities for collaborationIn a three-day strategic dialogue, Belgium and WHO reviewed progress in their longstanding partnership, and agreed to further boost their collaboration on universal health coverage, health-systems strengthening and…
Dünya Sağlık Örgütü (WHO) · 07.03.2025
WHO and Switzerland cement cooperation until 2028WHO and Switzerland have announced the renewal of their cooperation strategy for the period 2024-2028. In 2013, Switzerland became the first high-income country in the WHO European Region to pilot a cooperation…
Kaynaklar: Dünya Sağlık Örgütü (WHO), Avrupa Hastalık Önleme ve Kontrol Merkezi (ECDC), ABD Gıda ve İlaç Dairesi (FDA).